These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 15369590)

  • 21. Inhibitors of the Histone Methyltransferases EZH2/1 Induce a Potent Antiviral State and Suppress Infection by Diverse Viral Pathogens.
    Arbuckle JH; Gardina PJ; Gordon DN; Hickman HD; Yewdell JW; Pierson TC; Myers TG; Kristie TM
    mBio; 2017 Aug; 8(4):. PubMed ID: 28811345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spironolactone blocks Epstein-Barr virus production by inhibiting EBV SM protein function.
    Verma D; Thompson J; Swaminathan S
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3609-14. PubMed ID: 26976570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amplification of the Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 lytic origin of DNA replication is dependent upon a cis-acting AT-rich region and an ORF50 response element and the trans-acting factors ORF50 (K-Rta) and K8 (K-bZIP).
    AuCoin DP; Colletti KS; Cei SA; Papousková I; Tarrant M; Pari GS
    Virology; 2004 Jan; 318(2):542-55. PubMed ID: 14972523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Manipulation of the host cell membrane by human γ-herpesviruses EBV and KSHV for pathogenesis.
    Wei F; Zhu Q; Ding L; Liang Q; Cai Q
    Virol Sin; 2016 Oct; 31(5):395-405. PubMed ID: 27624182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of the unfolded protein response by 2-deoxy-D-glucose inhibits Kaposi's sarcoma-associated herpesvirus replication and gene expression.
    Leung HJ; Duran EM; Kurtoglu M; Andreansky S; Lampidis TJ; Mesri EA
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5794-803. PubMed ID: 22926574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potent antiviral activity of topoisomerase I and II inhibitors against Kaposi's sarcoma-associated herpesvirus.
    González-Molleda L; Wang Y; Yuan Y
    Antimicrob Agents Chemother; 2012 Feb; 56(2):893-902. PubMed ID: 22106228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silver nanoparticles selectively induce human oncogenic γ-herpesvirus-related cancer cell death through reactivating viral lytic replication.
    Wan C; Tai J; Zhang J; Guo Y; Zhu Q; Ling D; Gu F; Gan J; Zhu C; Wang Y; Liu S; Wei F; Cai Q
    Cell Death Dis; 2019 May; 10(6):392. PubMed ID: 31113937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tenofovir prodrugs potently inhibit Epstein-Barr virus lytic DNA replication by targeting the viral DNA polymerase.
    Drosu NC; Edelman ER; Housman DE
    Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12368-12374. PubMed ID: 32409608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV integrase inhibitors block replication of alpha-, beta-, and gammaherpesviruses.
    Yan Z; Bryant KF; Gregory SM; Angelova M; Dreyfus DH; Zhao XZ; Coen DM; Burke TR; Knipe DM
    mBio; 2014 Jul; 5(4):e01318-14. PubMed ID: 24987091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gammaherpesvirus Infection of Human Neuronal Cells.
    Jha HC; Mehta D; Lu J; El-Naccache D; Shukla SK; Kovacsics C; Kolson D; Robertson ES
    mBio; 2015 Dec; 6(6):e01844-15. PubMed ID: 26628726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity and mechanism of action of HDVD, a novel pyrimidine nucleoside derivative with high levels of selectivity and potency against gammaherpesviruses.
    Coen N; Singh U; Vuyyuru V; Van den Oord JJ; Balzarini J; Duraffour S; Snoeck R; Cheng YC; Chu CK; Andrei G
    J Virol; 2013 Apr; 87(7):3839-51. PubMed ID: 23345517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
    AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclooxygenase 2 induced by Kaposi's sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression.
    Sharma-Walia N; Raghu H; Sadagopan S; Sivakumar R; Veettil MV; Naranatt PP; Smith MM; Chandran B
    J Virol; 2006 Jul; 80(13):6534-52. PubMed ID: 16775340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus activates two major essential Epstein-Barr virus latent promoters.
    Groves AK; Cotter MA; Subramanian C; Robertson ES
    J Virol; 2001 Oct; 75(19):9446-57. PubMed ID: 11533207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiviral Properties of the LSD1 Inhibitor SP-2509.
    Harancher MR; Packard JE; Cowan SP; DeLuca NA; Dembowski JA
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of the KSHV and EBV lytic cycles to tumourigenesis.
    Manners O; Murphy JC; Coleman A; Hughes DJ; Whitehouse A
    Curr Opin Virol; 2018 Oct; 32():60-70. PubMed ID: 30268927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression.
    Vieira J; O'Hearn PM
    Virology; 2004 Aug; 325(2):225-40. PubMed ID: 15246263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency.
    Lan K; Murakami M; Choudhuri T; Kuppers DA; Robertson ES
    Virology; 2006 Aug; 351(2):393-403. PubMed ID: 16701788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Conserved Mechanism of APOBEC3 Relocalization by Herpesviral Ribonucleotide Reductase Large Subunits.
    Cheng AZ; Moraes SN; Attarian C; Yockteng-Melgar J; Jarvis MC; Biolatti M; Galitska G; Dell'Oste V; Frappier L; Bierle CJ; Rice SA; Harris RS
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31534038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infectious agents in human cancers: lessons in immunity and immunomodulation from gammaherpesviruses EBV and KSHV.
    Taylor GS; Blackbourn DJ
    Cancer Lett; 2011 Jun; 305(2):263-78. PubMed ID: 21470769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.